ScholarWorks@Gyeongsang National University: Hwang, Young-Sil

Detailed Information

Hwang, Young-Sil (황영실)

의과대학 (의학과)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Cisplatin:5||Pleural effusion:4||Nonsmall cell lung cancer:4||Gemcitabine:3||Tuberculosis:3||Prognostic marker:3||Pulmonary disease, chronic obstructive:3||ICU:3||Docetaxel:2||Platinum:2||Survival:2||ECMO:2||ARDS:2||Gabapentin:2||Lung assist device:2||Nonsmall cell lung cancer (NSCLC):2||Adenocarcinoma.:2||ADA:2||Critically ill:2||StevensJohnson syndrome:2||biomarker:2||Malignancy:2||Membrane vibration:2||Endobronchial aspergilloma:2||Mycobacterium tuberculosis:2||chronic obstructive pulmonary disease:2||Noncardiac patients:2||Intensive care unit:2||Cardiac troponin I:2||Amylase:2||ERCC1:1||ERCC2:1||Endobronchial mass:1||Endobronchial tuberculosis:1||Endothelial cells:1||Exercise tolerance:1||Fever:1||Fixed dose rate:1||Fluid balance:1||HIF1 alpha:1||Health care workers:1||Hydrocortisone:1||Immunochromatographic assay:1||Immunosuppression:1||Independent living:1||Interferongamma release tests:1||Intestinal perforation:1||Lactate:1||Latent tuberculosis:1||Latent tuberculosis infection (LTBI):1||Lung cancer:1||Lymphocyte/neutrophil ratio:1||MGIT:1||Mortality:1||Mucormycosis:1||Muscle, skeletal:1||Mycobacteria, atypical:1||Mycobacterium avium complex:1||Older people:1||Osteopontin:1||Oxidative stress:1||Phenotype:1||Pneumonia Severity Index:1||Pneumonia, communityacquired:1||Polymerase chain reaction, realtime:1||Procalcitonin:1||Pulmonary Tuberculosis:1||Pulmonary disease:1||Quality of life:1||QuantiFERONTB Gold assay:1||Radiologic Finding:1||Respiration, artificial:1||Respiratory insufficiency:1||Right middle lobe syndrome:1||Severe communityacquired pneumonia:1||Small cell lung cancer:1||Smoking:1||Strongyloides stercoralis:1||Survival Rate:1||Systemic inflammatory marker:1||TB Ag MPT64:1||Tracheal aspirate:1||Treatment:1||TroponinI:1||Tuberculin skin test (TST):1||Tuberculin test:1||Tuberculous Pneumonia:1||Weekly administration:1||Yacon:1||anaphylaxis:1||angiogenesis:1||angiopoietin2:1||antituberculosis treatment:1||bronchial washing:1||bronchoscopy:1||cancer:1||celecoxib:1||cisplatin:1||convalescence:1||critical ill patients:1||cytology:1||disease exacerbation:1||drug resistance:1||elderly:1||emphysema:1||endobronchial tuberculosis:1||exacerbation:1||hypotension:1||intensive care unit:1||intravenous immunoglobulin:1||irinotecan:1||isoniazid:1||lung cancer:1||mechanical ventilation:1||nonsmall cell lung cancer:1||osteopontin:1||outcome:1||platinum:1||pneumothorax:1||pulmonary:1||pulmonary tuberculosis:1||pumonary tuberculosis:1||respiratory failure.:1||right middle lobe syndrome:1||smallcell lung:1||smoke:1||survival:1||syncope:1||thrombocytopenia:1||urticaria:1||ABCG2:1||weight change.:1||AIDS:1||Acquired:1||Acute Respiratory Distress Syndrome(ARDS):1||Adrenal cortex hormones:1||Age:1||Alveolar Recruitment Maneuver(ARM):1||Angioinvasive:1||Antibiotic resistant:1||Antibiotics restriction:1||BMI:1||Biological markers:1||Biweekly administration:1||Blood stream infection:1||Body mass index:1||Body weight:1||COPD:1||CRP:1||Catabolic state:1||Cause:1||Causes:1||Chronic obstructive:1||Clinical characteristics:1||CommunityAcquired Pneumonia:1||Complications:1||Critically ill noncardiac patients:1||Critically ill patients:1||Diabetesmellitus:1||Disease exacerbation:1||Disease progression:1||

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0533

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE